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Abstract
Background: Hospital Acquired Infections (HAIs) are preventable; however, they continue to
occur. Many HAI’s can be prevented by adhering to the Centers for Disease Control and
Prevention (CDC) Healthcare Infection Control Guidelines. In late 2019 a novel virus, known as
SARS-CoV-2, or COVID-19, emerged and spread across the globe. CDC recommended
additional infection prevention and control practices during the COVID-19 pandemic, in addition
to standard practices. This study will compare HAI rates before and during the COVID-19
pandemic as well as between COVID and non-COVID units.
Methods: HAI data collected pre-COVID-19 and during COVID-19 will be compared to
determine if there are any differences in rates of Central Line Associated Blood Stream
Infections (CLABSI), Catheter Associated Urinary Tract Infections (CAUTI), and Ventilator
Associated Events (VAE). Data collected during COVID-19 will also be used to compare the
HAI rates between patients in COVID-19 units and non-COVID-19 units.
Results: VAE’s per 1,000 ventilator days were slightly greater in the pre-pandemic period than
during the COVID-19 pandemic (17.83 vs 17.04, p= 0.01). VAE’s were more likely to occur in
the COVID-19 units than in the non-COVID units (18.28 vs 16.50 per 1,000 ventilator days,
p=0.03). CLABSI and CAUTI rates did not have a significant difference (p>0.05).
Conclusion: The impact of COVID-19 on HAI prevention and control efforts is far-reaching.
There is an increase in critically ill hospitalized patients with long hospital stays and potential
diversion of traditional infection prevention and control resources. However, there is also
increased awareness of, and enhanced, prevention and control measures. Future work should
monitor trends associated with the COVID-19 pandemic and hospital acquired infection rates.
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Chapter 1 – Introduction
Problem Statement

Hospital acquired infections (HAI’s) are a significant cause of morbidity and mortality.
The Centers for Disease Control and Prevention (CDC) estimates that on any given day, 1 in 31
hospital patients has at least one HAI (CDC, 2021a). Many HAI’s can be prevented by following
CDC guidelines such as appropriate hand hygiene, disinfecting environments often, properly
monitoring patients, and wearing correct personal protective equipment (PPE) (CDC, 2016).

The SARS-CoV-2 virus emerged late 2019 and is the cause of COVID-19, which is now
a global pandemic. COVID-19 is a communicable respiratory virus with transmission occurring
from an infected person to another person through respiratory droplets and aerosols. COVID-19
has had a global impact causing economic and social disruption (ILO et al., 2020) and it is also
changing healthcare delivery. Due to COVID-19, existing safety protocols were updated, and
new protocols were created to prevent the spread of COVID-19 in healthcare settings. New
protocols included encouraging patients to wear masks upon arrival and throughout their visit,
separating patients by at least six feet if they cannot be isolated in their own rooms, hand hygiene
education and promotion to staff and patients, limiting visitors, and using telehealth services
when appropriate (CDC, 2021b).
The impact of COVID-19 on HAI’s is unclear. COVID-19 may increase the incidence of
HAI’s due to the increased number of critically ill hospitalized patients, especially patients
requiring mechanical ventilation. However, COVID-19 may also decrease the incidence of
HAI’s due to enhanced infection control practices. The goal of this project is to determine how
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COVID-19 affected rates of three HAI’s (CAUTI, CLABSI, and VAE) at the Nebraska Medical
Center located in in Omaha, Nebraska, the largest hospital in Nebraska. The null hypothesis
would be that there are no changes in CAUTI, CLABSI, or VAE rates between 2019 and 2020.
We will also explore the differences in rates of CAUTI, CLABSI and VAE between COVID-19
and non-COVID-19 units during 2020. The null hypothesis would be that there will be no
differences in CAUTI, CLABSI or VAE rates between COVID-19 and non-COVID-19 units.
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Chapter 2 – Background and Literature Review
Background

The CDC estimates that 1.7 million hospitalized patients in the United States will develop
a Hospital Acquired Infection (HAI) each year (Haque et al., 2018). A HAI is an infection that is
acquired in a health care setting. Some of the most common HAI’s are Catheter-Associated
Urinary Tract Infection (CAUTI), Central Line-Associated Bloodstream Infection (CLABSI),
Surgical Site Infection (SSI), Ventilator Associated Event (VAE), Clostridioides difficile (CDI),
Methicillin-resistant Staphylococcus aureus (MRSA), and Vancomycin-Resistant Enterococcus
(VRE). HAI’s are associated with risks such as increased hospital stays as well as an increase in
morbidity and mortality rates. Of the 1.7 million hospitalized patients in the U.S. that will
develop a HAI, an estimated 98,000 of them will die because of the infection (Haque et al.,
2018).

CAUTI occurs when a catheter that is inserted into the bladder causes an infection
anywhere in the urinary tract. Of all hospitalized patients, 15-25% of them will receive a urinary
catheter (CDC, 2015). The greatest risk factor for CAUTI is prolonged use of the catheter. Other
risk factors include being female, paraplegic, or other mobility issues, and having a history of
UTIs (CDC, 2015). The CDC’s Standardized Infection Ratio (SIR) summary reported 19,398
acute care hospital patients developing a CAUTI in 2019 and 22,015 in 2018 (Table 1). To
prevent CAUTI’s, catheters must be removed as soon as possible and only used when necessary.
Sterile environments are needed when inserting the catheter as well as around the drainage site to
prevent pathogens from entering, this also includes proper hand hygiene before performing any
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tasks around the catheter on the patient. Lastly, the catheter site should be frequently checked to
ensure no pulling, tugging, kinking, or twisting of the catheter is occurring.
CLABSI’s are when pathogens enter the bloodstream through a catheter placed into a
large vein in the neck, chest, or groin (CDC, 2010b). CLABSI results in thousands of deaths each
year and is the most expensive HAI, costing billions of dollars every year in the United States
(CDC, 2010b). The CDC’s SIR summary reported 18,009 patients in 2019 and 19,188 patients in
2018 that were in an acute care hospital and developed CLABSI (Table 1). The greatest risk
factors for developing CLABSI includes prolonged used of a central line, prolonged time spent
in an Intensive Care Unit (ICU), immunosuppressed patients, elderly patients, patients with
kidney disease, and those who live in developing countries (CDC, 2010b). CLABSI, as with all
HAI’s, are preventable. It is important to perform proper hand hygiene before conducting any
tasks, sterilizing the insertion site, removing the central line when it is no longer needed, and
replacing the dressings around the central line frequently.
VAE’s are when pathogens enter through the ventilator tubing and cause a lung infection.
It is estimated that 2-16 events occur per 1,000 ventilator days (Tismit et al., 2017). There are
three tiers to VAE’s, and they are defined through a VAE algorithm. The first tier is a Ventilator
Associated Condition (VAC) which is when a patient who was stable shows declining
respiratory status while on a ventilator for a minimum of two days (Peña-López et al., 2019). The
second tier is an Infection-related Ventilator-Associated Complication (IVAC) this is when a
patient from tier 1 shows signs and symptoms of an infection and/or develops a temperature and
is administered an antimicrobial agent for at least four days (Peña-López et al., 2019). The third
tier is Possible Ventilator Associated Pneumonia (PVAP) which is when a patient from tier 2 has
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a positive culture from a list of specific specimens or respiratory secretions and an identified
organism, or they have a positive respiratory test (Peña-López et al., 2019). The CDC’s SIR
summary recorded 24,724 VAE events in acute care hospitals in 2019 and 24,223 in 2018 (Table
1). One event is estimated to be $40,000 in health care costs and millions of dollars are spent on
Ventilator Associated Pneumonia (VAP) every year in the United States (Tismit et al., 2017).
Those at greatest risk are patients who are on a ventilator for a prolonged period, patients who
are elderly, immunocompromised, had a recent surgery, smokers, patients in a coma, severe burn
victims, and patients with coronary artery disease, diabetes, respiratory disease, or chronic renal
failure (Luckraz et al., 2017). Keeping a patient’s head raised, reducing time on a ventilator,
appropriate hand hygiene, rinsing out the patient’s mouth, and cleaning or replacing equipment
between patients can all prevent a VAE.

COVID-19 has resulted in the introduction of new guidelines and modified current
operation guidelines for healthcare settings. The new guidelines include mask mandates, policies
prohibiting hospital visitors, and maintaining six feet of distance between beds and patients.
Guidelines that were heightened due to COVID-19 are healthcare staff batching tasks while
caring for a patient to minimize visits into the room, cancelling elective surgeries, and increased
hand hygiene. These changes could affect the incidence of HAIs in the healthcare setting.
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Table 1: 2018 and 2019 CDC SIR Summary Report by Infection and Hospital Unit

Literature Review

A study conducted by Wee et al (2020) in the largest Singapore health care facility
compared rates from pre-COVID, January 2018 – January 2020, and during COVID, February 1,

10

2020 – August 31, 2020. They found that healthcare-associated respiratory-viral-infection and
MRSA rates decreased during the COVID pandemic compared to a pre-COVID time period. The
authors claimed declining rates were due to the increased compliance with standard precautions.
They were able to support this claim by finding that pre-COVID hand hygiene compliance was
at 85% and hand hygiene compliance during the COVID pandemic was 100% (Wee et al., 2020).
Wee et al. hypothesized that there would be an increase in HAI rates during the COVID-19
pandemic because an increase in HAI’s was observed during the 2003 SARS outbreak.

Another study by Cole and Barnard (2020) found a decline in HAI rates during the
COVID-19 pandemic. This study was conducted in four hospitals in Los Angeles, California,
and examined the rates of MRSA, VRE, and Extended Spectrum Beta-Lactamase (ESBL), all of
which are multi-drug resistant organisms (MDRO’s) (Cole et al., 2020). Pre-COVID rates were
taken from quarter 1 of 2020 and COVID rates were recorded from quarter 2 of 2020. Results
found a significant decrease in all MDRO rates during the COVID-19, quarter 2, period (Cole et
al., 2020).

Not all studies found a decrease in HAI rates during the COVID-19 pandemic.
McMullen, Smith, and Rebmann (2020) looked at New York City, New York, and St. Louis,
Missouri’s HAI rates. Their study found increased rates for CAUTI and CLABSI and decreased
rates for CDI. They hypothesized the increase in CAUTI and CLABSI rates was due to low
acuity patients staying home due to the pandemic while patients requiring urgent medical
attention were visiting the hospital. This decreased the denominator which subsequently
increased the infection rates. In McMullen, Smith, and Rebmann’s study, CDI rates decreased
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during the COVID-19 pandemic, it is presumed this is due to increased hand hygiene,
disinfecting the facility, mask mandates, and social distancing (McMullen et al., 2020).
It is unknown how the COVID-19 pandemic will impact HAI’s. Due to the COVID-19
pandemic, CDC set stricter guidelines for infection control, and this may help reduce HAI rates.
However, with higher acuity patients visiting the hospital and lower acuity patients staying home
there is a greater likelihood for hospitalized patients to develop an infection which would
increase the numerator for a HAI rate. This project will examine the rates of HAI’s, specifically
CAUTI, CLABSI, and VAE, pre-COVID pandemic and during COVID pandemic as well as
between the COVID and non-COVID units at Nebraska Medicine.
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Chapter 3 – Data and Methods
Design and Setting
The CDC’s National Healthcare Safety Network (NHSN) is an online surveillance
system which allows healthcare facilities to report and track HAI’s. NHSN provides definitions
and guidance for facilities to classify if an infection is present on admission or healthcare
associated (CDC, 2021c). Nebraska Medicine uses NHSN’s guidance and definitions to track
and report their HAI’s. Nebraska Medicine is in Omaha, Nebraska, and houses 718 licensed beds
(Nebraska Medicine, 2020).
This was a retrospective study using collected data from Nebraska Medicines summary
databases. Personnel at the Infection Control and Epidemiology Department at Nebraska
Medicine completed surveillance and defined HAIs which provided the CAUTI, CLABSI, and
VAE data. The spreadsheet included raw data for total infection count, number of device days,
and number of patient days by each hospital unit and month. The spreadsheet referenced if a
hospital unit was a COVID-19 unit or a non-COVID-19 unit for the year 2020.
We analyzed the data collected using a before-after study design comparing the preCOVID-19 (April 1, 2019 – Dec. 31, 2019) HAI rates to the COVID-19 (April 1, 2020 – Dec.
31, 2020) HAI rates. COVID-19 HAI rates will also be compared between the COVID-19 units
and the non-COVID-19 units to identify if COVID-19 patients were at greater risk for
developing a HAI than non-COVID-19 patients.
Variables
Variables included in the study were infection, device days, patient days, unit, and year.
Infections included CAUTI, CLABSI, and VAE. Device days were based on type of infection
and included central-line days, catheter days, and ventilator days. Units were either COVID or
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non-COVID and years were either 2019 or 2020. A new variable was created from existing data
which was infection per 1,000 device days. This variable was created by taking the infection
count divided by device days and multiplying by 1,000. Infection per 1,000 device days was
found for each month during both years, each month for both units, and in total for each year and
each unit.
Analysis
Differences between HAI rates pre-COVID-19 and during-COVID-19 as well as
differences between COVID and non-COVID units were assessed using paired t-test for each
infection. Infection rates were calculated per 1,000 device days. A p-value < .05 was set to
indicate statistical significance. SAS 9.4 software was used for statistical analysis.
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Chapter 4 – Results
2019 vs. 2020 Overview
From April 1, 2019, through December 31, 2019, there were a total of 127 infections,
62,025 device days and 285,354 patient days for CAUTI, CLABSI, and VAE. During April 1,
2020 – December 31, 2020, there were 64 more infections (n=191), 1,504 more device days
(n=63,529) and 3,473 less patient days (n=281,862) than the previous year.
Infection data for both years are summarized in Table 2. The most frequent HAI at
Nebraska Medicine from the three infections analyzed was VAE’s, accounting for 88 (69%) of
infections in 2019 and 134 (70%) in 2020. There were 22 (17%) CLABSI reports in 2019 and 28
(15%) in 2020, and 17 (13%) CAUTI reports in 2019 and 29 (15%) in 2020. VAE’s had the
greatest infection rate with 17.83 and 17.04 infections per 1,000 ventilator days in 2019 and
2020, compared to 0.5 and 0.7 infections per 1,000 central line days for CLABSI, and 1.1 and
1.9 infections per 1,000 catheter days for CAUTI.
Table 2: 2019 vs. 2020 Infection Data Results

2019 Data
Variable
CLABSI
CAUTI
VAE
Total

Infection Count
22
17
88
127

Device Days
41,510
15,579
4,936
62,025

Patient Days
134,388
127,916
23,031
285,354

Infection Rate1
0.53
1.09
17.83

Patient Days
132,141
126,396
23,325
281,862

Infection Rate1
0.69
1.89
17.04

2020 Data
Variable
Infection Count
Device Days
CLABSI
28
40,294
CAUTI
29
15,372
VAE
134
7,863
Total
191
63,529
1
Infection rate = (Infection count/Device days) *1000
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VAE Year Analysis
Figure 1 shows the total ventilator days at Nebraska Medicine broken down for each
month and color coded by year. In 2019, there were a total of 4,936 ventilator days from month 4
– month 12. In 2020, there were a total of 7,863 ventilator days from month 4 – month 12. There
was a 59% increase (n=2,927) in ventilator days during months 4 – 12 in 2020 when compared to
2019. Each month in 2020 had a greater number of ventilator days when compared to each
month in 2019. The largest monthly differences were in month 5 and in month 11. Month 5 had
643 (107%) more and month 11 had 659 (144%) more ventilator days than the previous year.
Figure 1: Ventilator Days by Month and Year

Figure 2 displays the ventilator associated events at Nebraska Medicine for each month
and year. In 2019 there were a total of 88 VAE’s from month 4 – 12 and in 2020 there were a
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total of 134 VAE’s. There were 46 (52%) more VAE’s in 2020 than in 2019. In 2020, each
month had a greater number of VAE’s when compared to the previous year except for in month
9 when VAE’s were the same for both years. Month 5 and month 11 had the greatest differences
between the two years, with 11 infections (73%) more in month 5 of 2020 and 10 infections
(142%) more in month 11 of 2020.

Figure 2: Ventilator Associated Events by Month and Year

Figure 3 shows a graph of the VAE rates per 1,000 ventilator days by month and each
year. The VAE rate for 2019 was 17.83 infections per 1,000 ventilator days and for 2020 the
VAE rate was 17.04 infections per 1,000 ventilator days. The peak infection rate in 2019 was
during month 5 with a rate of 24.7 infections per 1,000 ventilator days, and during month 10 in
2020 with 21.3 infections per 1,000 ventilator days. The lowest rate during 2019 was month 12
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with a rate of 11.4 infections per 1,000 ventilator days and during 2020 was month 6 with 13.2
infections per 1,000 ventilator days.
Figure 3: VAE Rates per 1k Ventilator Days by Month and Year

CLABSI Year Analysis
Figure 4 shows the total central line days at Nebraska Medicine by each month and color
coded for the two years. There was a total of 41,510 central line days in 2019 and 40,294 in
2020; a decrease of 1,216 device days (3%) from 2019 to 2020. During months 7, 10, and 11
2020 had greater central line days than 2019. The months with the greatest number of central line
days were month 8 in 2019 (n=4,959) and month 10 in 2020 (n=5,150). The months with the
lowest number of central line days were month 9 in 2019 (n=4,272) and month 4 in 2020
(n=3,396).
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Figure 4: Central Line Days by Month and Year

Figure 5 presents the total number of CLABSI’s at Nebraska Medicine for both years and
is broken down by month. There was a total of 22 CLABSI’s from month 4 – 12 in 2019 and 28
CLABSI’s from month 4 – 12 in 2020. There were 6 more CLABSI’s recorded in 2020
compared to 2019, an increase of 27%. CLABSI counts were greater in 2019 than 2020 during
months 11 and 12. Months 4 and 8 had the same number of CLABSI’s for both years (n=2 and
n=4). The peak for CLABSI’s was during month 12 of 2019 with a total of 5 infections and
month 6 of 2020 with a total of 6 infections. Month 9 of 2019 and month 11 of 2020 had 0
reported CLABSI’s.
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Figure 5: Central Line Associated Blood Stream Infections by Month and Year

Figure 6 displays a graph of CLABSI rates per 1,000 central line days for both years and
for each month. The CLABSI rate for 2019 was 0.53 infections per 1,000 central line days and
for 2020 was 0.69 infections per 1,000 central line days. Infection rates were greatest during
month 12, 2019 with 1.06 infections per 1,000 central line days and during month 6, 2020 with
1.42 infections per 1,000 central line days.
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Figure 6: CLABSI Rates per 1k Central Line Days by Month and Year

CAUTI Year Analysis
Figure 7 displays the total catheter days for both 2019 and 2020 by each month. In 2019
there was a total of 15,579 catheter days, and in 2020 there was a total of 15,372: a decrease of
207 (1.3%) catheter days from 2019 into 2020. Catheter days remained quite similar between the
two years except for month 5 which had a 50% decrease from 2019 to 2020 (1,765 vs. 1,180)
and in month 11 which had a 29% increase from 2019 to 2020 (1,598 vs. 2,065). The months
with the greatest number of catheter days was month 12 in 2019 (n=1,878), and month 11 in
2020 (n=2,065). The months with the lowest number of catheter days was month 4 and 11 during
2019 (n=1599 and n=1598) and during month 5 in 2020 (n=1,180).
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Figure 7: Catheter Days by Month and Year

Figure 8 shows the CAUTI’s at Nebraska Medicine for both years and by each month. In
2019, there was a total of 17 infections and in 2020 there was a total of 29 infections, an increase
of 70% from 2019 to 2020. During 2020, every month had a greater number of CAUTI’s than
2019 except for months 5, 7, and 9. Month 5 for both years had the same number of CAUTI’s
(n=2). The greatest number of CAUTI’s recorded in one month was 6 infections for both month
6 and month 11 in 2020. The greatest total infections in one month in 2019 was 3 in both months
6 and 12.
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Figure 8: Catheter Associated Urinary Tract Infections by Month and Year

Figure 9 illustrates a graph of CAUTI rates per 1,000 catheter days by month and each
year. The CAUTI rate for 2019 was 1.09 infections per 1,000 catheter days and in 2020 was 1.88
infections per 1,000 catheter days. The highest CAUTI rate for both years was during month 6,
in 2019 the rate was 1.65 infections per 1,000 catheter days and in 2020 the rate was 3.19
infections per 1,000 catheter days. Months 5, 6, 8, 10, 11, and 12 during 2020 had CAUTI rates
greater than the peak rate in 2019. The lowest CAUTI rate in 2019 was during month 10 with a
rate of 0.56 infections per 1,000 catheter days and during 2020 was in month 7 with an infection
rate of 0.58 infections per 1,000 catheter days.
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Figure 9: CAUTI Rates per 1k Catheter Days by Month and Year

2019 vs. 2020 Summary
Compared to the pre-COVID-19 period, VAE rates had a slight decrease (5%) in
infection rates during the COVID-19 pandemic from 17.83 to 17.04 per 1,000 ventilator days
(p=0.01). There were no significant differences (p > 0.05) detected in CLABSI and CAUTI rates
between 2019 and 2020.

COVID vs. non-COVID Unit Overview
During the pandemic period (April 1, 2020 – December 31, 2020) there were a total of
191 infections, 63,529 device days, and 281,862 patient days. The non-COVID units accounted
for 70% (n=134) of the infections, 85% (n=53,724) of the device days, and 84% (n=236,721) of
the patient days in 2020 for the three HAIs being analyzed.
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Infection data for COVID and non-COVID units are described in Table 3. In the COVID
units VAE’s accounted for 77% (n=44) of infections, CLABSI for 11% (n=6) and CAUTI for
12% (n=7). In the non-COVID units 67% of infections were VAE’s (n=90), 16% (n=22) were
CLABSI, and 16% (n=22) were CAUTI. VAE’s had the largest infection rate in both COVID
and non-COVID units when compared to CLABSI and CAUTI rates. VAE’s had an infection
rate of 18.28 infections per 1,000 ventilator days in the COVID unit and 16.50 infections per
1,000 ventilator days in the non-COVID unit. CLABSI had 1.35 infections per 1,000 central line
days in the COVID units and 0.61 infections per 1,000 central line days in the non-COVID units.
CAUTI recorded 2.36 infections per 1,000 catheter days in COVID units and 1.77 infections per
1,000 catheter days in non-COVID units.
Table 3: COVID-19 vs. non-COVID-19 Unit Data Results

COVID Units
Variable
CLABSI
CAUTI
VAE
Total

Infection Count
6
7
44
57

Device Days
4,430
2,968
2,407
9,805

Patient Days
18,896
18,896
7,349
45,141

Infection Rate1
1.35
2.36
18.28

Non-COVID Units
Variable
Infection Count Device Days
Patient Days
CLABSI
22
35,864
113,245
CAUTI
22
12,404
107,500
VAE
90
5,456
15,976
Total
134
53,724
236,721
1
Infection rate = (Infection count/Device days) *1000

Infection Rate1
0.61
1.77
16.50

VAE Unit Analysis
Table 4 displays the VAE data for both COVID and non-COVID units. The COVID unit
had a total of 44 VAE’s, 2,407 ventilator days, and a VAE rate of 18.28 infections per 1,000
ventilator days. The non-COVID units reported 90 VAE’s, 5,456 ventilator days, and a VAE rate
25

of 16.50 infections per 1,000 ventilator days. Throughout 2020 the hospital changed unit statuses
based on need, the ‘number of units’ column on table 4 shows the total number of units during
each month of 2020. During months 4 – 9 of 2020 there were 2 COVID units reporting VAE
data at Nebraska Medicine and for months 10 – 12 there were 3 COVID units reporting VAE
data. Months 4 – 12 of 2020 had 5 non-COVID units reporting VAE data.
Table 4: VAE Data by Unit

VAE COVID Units
Month
M04
M05
M06
M07
M08
M09
M10
M11
M12
Total

Infection
Count
2
13
8
2
5
5
4
3
2
44

Device
Days
181
494
372
213
206
236
186
311
208
2,407

Infection
Rate1
11.05
26.32
21.51
9.39
24.27
21.19
21.51
9.65
9.62
18.28

Number
of Units
2
2
2
2
2
2
3
3
3

Mean Infections
per Unit2
1.00
6.50
4.00
1.00
2.50
2.50
1.33
1.00
0.67

Mean Device
Days per Unit3
90.50
247.00
186.00
106.50
103.00
118.00
62.00
103.67
69.33

VAE non-COVID Units
Infection Device Infection Number
Mean Infections
Count
Days
Rate1
of Units
per Unit2
M04
8
521
15.36
5
1.60
M05
13
756
17.20
5
2.60
M06
5
615
8.13
5
1.00
M07
11
539
20.41
5
2.20
M08
7
573
12.22
5
1.40
M09
7
454
15.42
5
1.40
M10
14
661
21.18
5
2.80
M11
14
804
17.41
5
2.80
M12
11
533
20.64
5
2.20
Total
90
5,456
16.50
1
Infection Rate = (infection count) / (device days) *1000
2
Mean Infections per Unit = (infection count) / (number of units)
3
Mean Device Days per Unit = (device days) / (number of units)
Month

Mean Device
Days per Unit3
104.20
151.20
123.00
107.80
114.60
90.80
132.20
160.80
106.60
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The non-COVID-19 units had 46 (104%) more VAE’s than the COVID-19 units from
month 4 – month 12 in 2020. VAE’s were greater in the non-COVID units every month except
for month 5 and month 6. During month 5, both types of units had an equal number of VAE’s
(n=13) however, non-COVID units had 50% more ventilator days as well as more units in the
hospital. During month 6 the COVID units had a total of 8 VAE’s while the non-COVID units
had a total of 5 VAE’s, yet again the non-COVID units had 65% more ventilator days and more
units in the hospital.
The total VAE rate for COVID-19 units was 18.28 per 1,000 ventilator days and the total
VAE rate for non-COVID-19 units was 16.50 per 1,000 ventilator days. The greatest peak in the
COVID units was in month 5 with a rate of 26.32 VAE’s per 1,000 ventilator days. Month 5 was
also the month that the COVID unit experienced the largest number of VAE’s (n=13). The
lowest rate for the COVID units was during month 7 with a rate of 9.39 VAE’s per 1,000
ventilator days; months 11 and 12 also had a rate of 9.65 and 9.62 per 1,000 ventilator days. For
the non-COVID units the rate peaked during month 10 with a rate of 21.18 VAEs per 1,000
ventilator days. The lowest rate for the non-COVID units was during month 6 with a rate of 8.12
VAE’s per 1,000 ventilator days. When comparing the peak rates between units, the COVID
units had a peak rate 5.14 infections greater than the non-COVID units’ peak. Months 6, 8, 9,
and 10 for the COVID units had rates greater than the peak rate in the non-COVID units.
CLABSI Unit Analysis
Table 5 illustrates the CLABSI data for COVID and non-COVID units by each month in
2020. There was a total of 6 infections, 4,430 central line days, and a rate of 1.35 infections per
1,000 central line days from the COVID units. The non-COVID units experienced 22 infections,
35,864 central line days, and 0.61 infections per 1,000 central line days.
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Table 5: CLABSI Data.by Unit

CLABSI COVID Units
Month

Infection
Count

Device
Days

Infection
Rate1

Number
of Units

Mean Infections
per Unit2

M04
M05
M06
M07
M08
M09
M10
M11
M12
Total

0
1
3
0
0
1
1
0
0
6

269
673
607
372
309
409
380
704
707
4,430

0.00
1.49
4.94
0.00
0.00
2.44
2.63
0.00
0.00
1.35

3
4
4
3
3
3
5
8
8

0.00
0.25
0.75
0.00
0.00
0.33
0.20
0.00
0.00

Mean
Device Days
per Unit3
89.67
168.25
151.75
124.00
103.00
136.33
76.00
88.00
88.38

CLABSI non-COVID Units
Month

Infection
Count

Device
Days

Infection
Rate1

Number
of Units

Mean Infections
per Unit2

M04
2
3,127
0.64
23
M05
3
3,938
0.76
22
M06
3
3,614
0.83
22
M07
4
4,413
0.91
23
M08
4
4,122
0.97
23
M09
1
3,670
0.27
23
M10
3
4,770
0.63
23
M11
0
4,374
0.00
21
M12
2
3,836
0.52
21
Total
22
35,864
0.61
1
Infection Rate = (infection count) / (device days) *1000
2
Mean Infections per Unit = (infection count) / (number of units)
3
Mean Device Days per Unit = (device days) / (number of units)

0.09
0.14
0.14
0.17
0.17
0.04
0.13
0.00
0.10

Mean
Device Days
per Unit3
135.96
179.00
164.27
191.87
179.22
159.57
207.39
208.29
182.67

The COVID and non-COVID units changed throughout 2020 based on needs of the
hospital. COVID units ranged from 3-8 units throughout 2020 while non-COVID units ranged
from 21-23 units. While the non-COVID units reported 31,434 (710%) more device days, when
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dividing the total device days by the number of units, the COVID and non-COVID units had
similar mean device days per unit. However, non-COVID units still had greater mean device
days per unit for all analyzed months of 2020.
There were 16 more infections from the non-COVID units than the COVID units during
2020. Months 6, 9, and 11 had the same number of infections for the COVID and non-COVID
units, all other months the non-COVID units had greater numbers of infections. During month 11
both COVID and non-COVID units reported 0 infections. While COVID and non-COVID units
had the same number of infections for months 6 and 9, the COVID units infection rate was
greater for both months, 4.94 vs. 0.83 and 2.44 vs. 0.27, respectively.
The overall CLABSI rate for COVID units was 1.35 infections per 1,000 central line days
and for the non-COVID units was 0.61 infections per 1,000 ventilator days. The COVID units
had a peak infection rate during month 6 with a rate of 4.94 infections per 1,000 central line
days, this was also the COVID unit’s largest infection reporting month. The non-COVID unit’s
peak infection rate was during month 8 with a rate of 0.97 infections per 1,000 central line days.
Months 5, 6, 9, and 10, which is also every month the COVID units had reported at least one
infection, had a greater infection rate than the peak rate for the non-COVID units.
CAUTI Unit Analysis
Table 6 shows CAUTI data for both COVID and non-COVID units by each month from
April 1, 2020, through December 31, 2020. The COVID units reported 7 infections, 2,968
catheter days, and a CAUTI rate of 2.36 infections per 1,000 catheter days. The non-COVID
units reported 22 infections, 12,404 catheter days, and a CAUTI rate of 1.77 infections per 1,000
catheter days.
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Table 6: CAUTI Data by Unit

CAUTI COVID Units
Month
M04
M05
M06
M07
M08
M09
M10
M11
M12
Total

Infection
Count
0
2
3
0
0
0
0
1
1
7

Device
Days
216
288
384
268
313
340
249
474
436
2,968

Infection
Rate1
0.00
6.94
7.81
0.00
0.00
0.00
0.00
2.11
2.29
2.36

Number
of Units
3
4
4
3
3
3
5
8
8

Mean Infections
per Unit2
0.00
0.50
0.75
0.00
0.00
0.00
0.00
0.13
0.13

Mean Device Days
per Unit3
72.00
72.00
96.00
89.33
104.33
113.33
49.80
59.25
54.50

CAUTI non-COVID Units
Infection Device Infection Number
Mean Infections
Count
Days
Rate1
of Units
per Unit2
M04
2
1218
1.64
18
0.11
M05
0
892
0.00
17
0.00
M06
3
1497
2.00
17
0.18
M07
1
1466
0.68
18
0.06
M08
3
1418
2.12
18
0.17
M09
1
1259
0.79
18
0.06
M10
4
1763
2.27
18
0.22
M11
5
1591
3.14
16
0.31
M12
3
1300
2.31
16
0.19
Total
22
12,404
1.77
1
Infection Rate = (infection count) / (device days) *1000
2
Mean Infections per Unit = (infection count) / (number of units)
3
Mean Device Days per Unit = (device days) / (number of units)
Month

Mean Device Days
per Unit3
67.67
52.47
88.06
81.44
78.78
69.94
97.94
99.44
81.25

Unit statuses (COVID vs. non-COVID) were changed throughout 2020 based on need,
this is shown in the ‘number of units’ column in table 6. There were 3-8 COVID units and 16-18
non-COVID units reporting CAUTI data throughout 2020.
Non-COVID units reported 15 more infections and 9,436 more catheter days than the
COVID units throughout 2020. Each month, except for months 4, 5, and 6, the non-COVID units
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had a greater number of infections. During month 6 both types of units reported 3 infections still,
the COVID units had a greater infection rate than the non-COVID units, 7.81 vs 2.00.
The COVID unit’s overall infection rate was 2.36 infections per 1,000 catheter days. The
non-COVID unit’s overall infection rate was 1.77 infections per 1,000 catheter days. The
COVID units had a peak infection rate during month 6 with a rate of 7.81 infections per 1,000
catheter days. Non-COVID units had a peak infection rate during month 11 with an infection rate
of 3.14 infections per 1,000 catheter days.

COVID vs. non-COVID Unit Summary
We can conclude from April 1, 2020, to December 31, 2020, there was an increase in
VAE rates in the COVID units when compared to the non-COVID units (p=0.03). There was no
significant difference (p>0.05) detected in CLABSI and CAUTI rates between the COVID and
non-COVID units.
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Chapter 5 – Discussion
This study analyzed three incidence rates for three HAIs before and during the COVID19 pandemic as well as between types of units during the COVID pandemic at Nebraska
Medicine in Omaha, Nebraska. Due to the presence of a novel virus, that spread to become a
global pandemic, the CDC updated existing operation guidelines and introduced new guidelines
for healthcare facilities. These guidelines included mask mandates, prohibiting hospital visitors,
six feet of social distancing, increased hand hygiene, cancelling elective surgeries, new
procedures for donning and doffing PPE, healthcare staff batching tasks while visiting patients,
and more. Healthcare facilities also encouraged the use of telehealth services, when appropriate,
to limit visitors and limit potential COVID-19 transmission. The goal of this project was to
determine if the COVID-19 pandemic affected HAI rates when compared to pre-pandemic rates
and if there was a difference in HAI rates between COVID and non-COVID units. The COVID19 pandemic could have caused an increase in HAI incidence rates due to an increased number
of critically ill hospitalized patients visiting healthcare facilities. Nevertheless, the COVID-19
pandemic could have decreased HAI rates due to the adherence to CDC’s enhanced infection
prevention guidelines.
When examining HAI’s, we found that VAE rates were higher in the pre-pandemic
observational period than during the pandemic. The pre-pandemic observational period (April 1,
2019 – December 31, 2019) had a VAE incidence rate of 17.83 infections per 1,000 ventilator
days. During the pandemic period (April 1, 2020 – December 31, 2020) the VAE incidence rate
was 5% lower than the pre-pandemic period, a reported infection rate of 17.04 infections per
1,000 ventilator days (p=0.01). However, ventilator days and infection counts were greater
during the COVID-19 pandemic when compared to the pre-pandemic time frame. A study by
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Weinberger, Rhee, and Klompas (2021) also found that ventilator days and VAE’s were greater
during the COVID-19 pandemic when compared to pre-pandemic time frames. On the other
hand, they reported that rates per 1,000 ventilator days were similar compared to prior years
(p>0.05).
Though rates were slightly greater in the pre-pandemic period, it is important to note that
the number of VAE’s increased by 52% in 2020 compared to 2019 (134 vs. 88) and ventilator
days increased by 85% (7,863 vs. 4,235). Ventilator days increased at a greater margin compared
to the number of VAE’s, resulting in a larger denominator when calculating the rate per 1,000
ventilator days. With the CDC implementing guidelines to help prevent the COVID-19 virus
from spreading, adherence to these guidelines could have helped prevent other infections, such
as CAUTI, CLABSI, and VAE. One of the best VAE prevention methods is proper hand
hygiene, which was greatly encouraged during the COVID-19 pandemic. It is also likely that
limiting hospital visitors, separating patients into separate rooms; or by a minimum of six feet if
separate rooms were not an option; and wearing face masks reduced the amount of pathogens in
the environment. It is possible the VAE infection count did not increase proportional to the
increase in ventilator days due to the adherence to CDC guidelines that helped prevent infections
during the pandemic.
A study by Fakih et al. (2021) analyzed CAUTI and CLABSI rates pre-COVID-19
pandemic and during the COVID-19 pandemic. Their study found a 51% increase, 0.56 to 0.85
infections per 1,000 central line days, for CLABSI rates from pre-pandemic to during-pandemic
periods. Our study found there were not significantly different rates of CLABSI between prepandemic (0.53 per 1,000 central line days) to pandemic periods (0.69 per 1,000 central line
days; p=0.08). Fakih et al.’s study reported CAUTI rates did not show a statistically significant
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difference in rates between the pre-COVID period and the COVID period (p=0.19). Our study
also found there was not a statistically significant difference in CAUTI rates from the prepandemic (1.09 per 1,000 catheter days) and pandemic period (1.89 per 1,000 catheter days;
p=0.17).
While our study did not find statistical significance, other studies have, and they found an
increase in rates from pre-pandemic to the pandemic period. Some risk factors for CLABSI
infections are patients who are elderly, immunosuppressed, in an ICU, and those with kidney
disease. The CDC reported 190,509 COVID-19 associated hospitalizations from March 2020 –
July 2021 in the United States. Of the 190,509 patients, 43.5% (n=82,839) of them were ages 65
or older (CDC, 2021d). The CDC has also reported of COVID-19 associated hospitalizations
10.2% of adults and 4.7% of pediatric patients are immunosuppressed and 16.4% of adults and
1.1% of pediatric patients have renal disease (CDC, 2021d).
Our study also compared the COVID and non-COVID units at Nebraska Medicine during
the COVID-19 pandemic observation period. There was no statistical difference between CAUTI
or CLABSI and the different types of units (p=0.09, p=0.23). We found that the COVID-19 units
had a greater VAE rate per 1,000 ventilator days than the non-COVID units, 18.28 vs 16.50 per
1,000 ventilator days (p=0.03). COVID-19 units had fewer ventilator days (2,407 vs. 5,456) and
fewer VAE’s (44 vs. 90) than the non-COVID units. It is important to remember that there were
two to three more non-COVID units reporting VAE data than COVID units throughout 2020. A
study by Weinberger, Rhee, and Klompas (2021) found that COVID-19 patients had higher VAE
rates than those without COVID-19, 17.2 vs 12.3 per 1,000 ventilator days. They also observed
that those with COVID-19 had fewer reported infections than those without COVID-19.
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Of the 190,509 COVID-19 associated hospitalized patients in the United States, the CDC
reported 20.1% of adults and 4.9% of pediatric patients have chronic lung disease and 12.3% of
adults and 14.6% of pediatric patients have asthma (CDC, 2021d). One may assume that due to
COVID-19 being a respiratory virus the patients with compromised lungs were at greater risk of
needing a ventilator and developing an infection. The CDC reported that 8.2% of COVID-19
associated hospitalized adult patients and 46.5% of pediatric patients had no known underlying
medical conditions. Risk factors for HAI’s include underlying health conditions such as
immunosuppressed, kidney disease, coronary artery disease, diabetes, respiratory disease, and
chronic renal failure. Another possibility for increased HAI infection in the COVID units is time
healthcare staff spend in the patient’s room. Healthcare staff may have been attempting to limit
exposure to the COVID-19 virus by batching tasks and completing tasks as quickly as possible.
This could result in omitting tasks proven to decrease HAIs such as adjusting patients bed
position, rinsing the patient’s mouth, replacing dressings, checking the devices for any damage,
or ensuring devices have proper water levels or are inserted correctly.

Strengths and Limitations
The COVID-19 pandemic is ongoing and the impact of the pandemic on HAI’s is still
being studied. The use of NHSN at Nebraska Medicine allows for tracking of HAI’s over
multiple years and the detection of problematic areas in a healthcare facility. Due to the COVID19 pandemic, longitudinal data can be compared and solutions to preventing HAI’s may be
found.
Our study has some limitations. First, was not having detailed data on device
occurrences. We were unable to identify how many device events occurred for each infection
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and were only provided data on how many total device days. Without knowing how many events
occurred we were unable to identify any outliers for device days. Second, we were not provided
the number of beds in each unit. If the different types of units had large differences for their bed
capacities, then device days and infection events may be impacted.

Conclusion
Our study found statistically significant differences for VAEs between 2019 and 2020
and between the COVID units and non-COVID units, which may have been due to the COVID19 pandemic. Future studies should continue to explore significant differences between rates and
the COVID-19 pandemic as well as possible explanations for differences. This study saw a slight
decrease in VAE rates during the COVID-19 pandemic compared to the pre-pandemic period.
We also observed an increase of VAE rates in the COVID-19 units compared to the non-COVID
units. Whether the above differences were due to enhanced infection prevention and control
measures, greater numbers of critically ill hospitalized patients, or an alternative reason, suggests
further investigation is warranted. This study concludes that there was an impact on HAI’s due to
the COVID-19 pandemic and it is important to continue to explore solutions to prevent hospital
acquired infections in the future.
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Application of Public Health Competencies
Epidemiology Competencies
EPIMPH1: Determine strengths and weaknesses of the scientific literature and synthesize the
evidence to inform public health practice
Throughout my capstone project I conducted literature reviews to find strengths and
weaknesses to apply into, or withdraw, from my project. Conducting literature reviews helped
discover what healthcare facilities in other states and countries are finding in relation to HAI
rates and COVID-19.
EPIMPH3: Analyze datasets using computer software.
For my capstone project I used Nebraska Medicines Infection Control data on Hospital
Acquired Infections pre-COVID and throughout the COVID-19 pandemic. I used this data and
conducted statistical tests to analyze if rates have changed due to the COVID-19 pandemic. I also
used this data and conducted statistical tests to analyzed if rates were different between COVID
and non-COVID units. All analyses in my capstone were conducted using SAS software.

Foundational Competency
MPHF4: Interpret results of data analysis for public health research, policy or practice
For my capstone project I used SAS software to analyze the Nebraska Medicine Infection
Control HAI data. I ran statistical tests to analyze the data and discovered changes in rates from
the pre-COVID period to the COVID-19 pandemic period. These results will be able to provide
public health knowledge on whether greater adherence to COVID-19 protocols and CDC
guidelines increase, decrease, or have no change in HAI rates.
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